BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2016
View Archived Issues
Selecta Biosciences announces new gene therapy programs
Read More
Novartis reviews highlights of second quarter 2016
Read More
Ruxolitinib receives orphan drug designation in U.S. for the treatment of ALL
Read More
Merck & Co. announces BTK inhibitors
Read More
Angion Biomedica presents aldosterone synthase inhibitors
Read More
FORMA Therapeutics patents ubiquitin hydrolase inhibitors
Read More
The Vanderbilt University reports mGlu2 receptor modulators
Read More
Shire launches pediatric indication for HyQvia in Europe
Read More
RBPJ inhibition as promising new therapeutic strategy for ischemic injury
Read More
EMA proposes changes to guidance on first-in-human trials
Read More
BiopharmX reports PK data for BPX-01
Read More
Helix BioPharma subsidiary finalizes Polish grant funding to support development of V-DOS47
Read More
RepliCel Life Sciences product cleared for clinical research in Japan
Read More
Newron Pharmaceuticals begins sarizotan study in Rett syndrome
Read More
Puma submits NDA for neratinib as extended adjuvant in HER2-positive early stage breast cancer
Read More
ABX-464 well tolerated in first study in HIV-infected patients, another under way
Read More
FDA issues complete response letter for latanoprostene bunod NDA
Read More
FDA requests new data and analyses to support bezlotoxumab BLA
Read More
SPHERE Registry to validate biomarkers in urine that predict genetic mutations
Read More
Cytox launches genetic biomarker test for assessing Alzheimer's disease risk
Read More
Cancer-prone BMF syndrome may be caused by mutations in DNAJC21
Read More
Amgen and UCB submit romosozumab BLA for osteoporosis in postmenopausal women
Read More
Novel Chlamydia vaccine using C. trachomatis T3SS proteins shows promise
Read More
Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment
Read More
FDA gives fast track status to axalimogene filolisbac
Read More
Enhanced neural activity and mTOR signaling promotes regeneration of adult retinal axons
Read More
Novan begins dosing in phase II SB-208 study
Read More
FDA grants breakthrough therapy designation to Spark Therapeutics' SPK-9001
Read More
Amgen and Allergan report phase III results for ABP-980
Read More
